Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Angle Share Price
  4. Angle Share News
  5. UK Earnings, Trading Statements Calendar - Next 7 Days

Pin to quick picksAngle Share News (AGL)

Angle Information

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.00
Bid: 20.50
Ask: 21.50
Change: 3.25 (18.31%)
Spread: 1.00 (4.878%)
Open: 18.50
High: 23.50
Low: 18.50
Prev. Close: 17.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 23rd Jan 2020 16:10

Friday 24 January 
Hansard GlobalTrading Statement
easyHotelFull Year Results
Marston's Trading Statement
Monday 27 January 
Petra DiamondsTrading Statement
Sthree Full Year Results
ITM PowerHalf Year Results
SSETrading Statement
Tuesday 28 January 
Mortgage Advice BureauTrading Statement
Learning TechnologiesTrading Statement
Crest NicholsonFull Year Results
UDG HealthcareTrading Statement
LucecoTrading Statement
PZ CussonsHalf Year Results
Euromoney Institutional InvestorTrading Statement
Virgin Money UKTrading Statement
Airtel AfricaQ3 Results
McCarthy & StoneFull Year Results
DP EurasiaTrading Statement
AG BarrTrading Statement
Greencore GroupQ1 Results
Wednesday 29 January 
Brewin DolphinQ1 Results
FDM GroupTrading Statement
FresnilloQ4 Production
Hargreaves ServcesHalf Year Results
ScS GroupTrading Statement
Wizz Air HoldingsQ3 Results
BangoTrading Statement
Thursday 30 January 
Royal Dutch ShellFull Year Results
UnileverFull Year Results
DiageoHalf Year Results
CentaminQ4 Production
Best of the BestHalf Year Results
Haynes PublishingHalf Year Results
AngleHalf Year Results
Renishaw Half Year Results
MITIE GroupQ3 Results
EvrazTrading Statement 
TclarkeTrading Statement 
BT GroupQ3 Results
Rank GroupHalf Year Results
3i GroupQ3 Results
Intermediate CapitalQ3 Results
St James's PlaceTrading Statement 
Paragon Banking GroupTrading Statement 
KAZ MineralsQ4 Production
Fuller, Smith & TurnerTrading Statement 
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Feb 2020 15:25

Angle upbeat on German research into 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Monday that University Medical Centre Hamburg-Eppendorf has published results of work undertaken to assess the analytical and clinical performance of 'Parsortix' in multiple metastatic cancer types, with the main emphasis on metastatic breast cancer.

Read more
11 Feb 2020 10:51

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Read more
11 Feb 2020 07:41

Angle upbeat on research into Parsortix with melanoma patients

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that a customer, the Edith Cowan University in Perth, Western Australia, has published results of research into the use of its 'Parsortix' system with melanoma patients.

Read more
30 Jan 2020 11:41

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

Read more
22 Jan 2020 11:00

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Read more
7 Nov 2019 13:50

Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma

Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma

Read more
31 Oct 2019 15:38

Angle Submits Positive Test Results For Parsortix System To US FDA

Angle Submits Positive Test Results For Parsortix System To US FDA

Read more
4 Oct 2019 15:17

Angle upbeat on patent grant for prostate cancer blood assessment

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the Queen Mary University of London (QMUL) European patent covering the measurement of the number of megakaryocytes in a patient blood sample as an assessment of the prognosis for prostate cancer has been granted.

Read more
4 Oct 2019 08:58

Angle Notes Queen Mary University's European Cancer Prognosis Patent

Angle Notes Queen Mary University's European Cancer Prognosis Patent

Read more
4 Sep 2019 14:09

Angle Reports Positive Study Results For Parsortix System

(Alliance News) - Angle PLC on Wednesday noted positive results from a study of its Parsortix system in small cell lung cancer.Parsortix is Angle's liquid biopsy technology, meaning it

Read more
29 Aug 2019 10:57

Angle Ovarian Cancer Testing Platform Study Enrols First Patients

(Alliance News) - Liquid biopsy firm Angle PLC said Thursday the first patients for its ovarian cancer test study have been enrolled ahead of anticipated completion early in 2020.The study

Read more
29 Aug 2019 09:12

Angle initiates main phase of ovarian cancer clinical study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the main phase of its 200-patient ovarian cancer clinical verification study has been initiated and the first patient has been enrolled.

Read more
22 Jul 2019 12:53

Angle's Parsortix Used For Analysis Of Circulating Tumor Cells

(Alliance News) - Angle PLC on Monday said one of its leading customers, the Disseminated Cancer Cell Network, has published new results of work done to develop a "robust, reliable and for of

Read more
25 Jun 2019 08:16

Angle looks to strengthen balance sheet and extend runway via placement

(Sharecast News) - Liquid biopsy company Angle will look to raise up £18m at 61.5p per ordinary share through finnCap and WG Partners in order to strengthen its balance sheet and enable the development of key products.

Read more
67891011121314

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.